

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.74201138 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.67947930 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.67947930 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.36539649 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.36539649 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 7.00497238 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.61747489 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.40741147 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.40741147 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.40741147 |
| 11 | glyoxylate metabolic process (GO:0046487) | 6.27272044 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.10936202 |
| 13 | tryptophan metabolic process (GO:0006568) | 6.02872357 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.88848376 |
| 15 | cysteine metabolic process (GO:0006534) | 5.79570723 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66839420 |
| 17 | blood coagulation, intrinsic pathway (GO:0007597) | 5.44712000 |
| 18 | urea metabolic process (GO:0019627) | 5.42913913 |
| 19 | urea cycle (GO:0000050) | 5.42913913 |
| 20 | lysine catabolic process (GO:0006554) | 5.39580507 |
| 21 | lysine metabolic process (GO:0006553) | 5.39580507 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39393575 |
| 23 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.39107329 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.36887643 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.36646374 |
| 26 | homocysteine metabolic process (GO:0050667) | 5.23004061 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.21538646 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 5.09366152 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 5.09212824 |
| 30 | intestinal cholesterol absorption (GO:0030299) | 5.02420394 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.01711568 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.01524123 |
| 33 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.97445962 |
| 34 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.97445962 |
| 35 | regulation of plasminogen activation (GO:0010755) | 4.97442150 |
| 36 | protein carboxylation (GO:0018214) | 4.96844721 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.96844721 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95492150 |
| 39 | bile acid metabolic process (GO:0008206) | 4.95350249 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.94808632 |
| 41 | regulation of fibrinolysis (GO:0051917) | 4.90344835 |
| 42 | protein activation cascade (GO:0072376) | 4.85698864 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.82772760 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.78904161 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.76622575 |
| 46 | regulation of complement activation (GO:0030449) | 4.63758848 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.58873857 |
| 48 | complement activation, classical pathway (GO:0006958) | 4.55932807 |
| 49 | negative regulation of protein activation cascade (GO:2000258) | 4.53939834 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 4.53887497 |
| 51 | drug transmembrane transport (GO:0006855) | 4.52165653 |
| 52 | acute-phase response (GO:0006953) | 4.52052185 |
| 53 | plasma lipoprotein particle organization (GO:0071827) | 4.51012623 |
| 54 | oxidative demethylation (GO:0070989) | 4.50556055 |
| 55 | drug catabolic process (GO:0042737) | 4.49418873 |
| 56 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.48351122 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 4.48280929 |
| 58 | protein-lipid complex assembly (GO:0065005) | 4.47881170 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 4.47184378 |
| 60 | glutamate metabolic process (GO:0006536) | 4.46072946 |
| 61 | regulation of humoral immune response (GO:0002920) | 4.45569933 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.45418514 |
| 63 | complement activation (GO:0006956) | 4.45170772 |
| 64 | negative regulation of hemostasis (GO:1900047) | 4.43033147 |
| 65 | negative regulation of blood coagulation (GO:0030195) | 4.43033147 |
| 66 | glycine metabolic process (GO:0006544) | 4.41079417 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.40660029 |
| 68 | amine catabolic process (GO:0009310) | 4.40660029 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 4.39124950 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.36950389 |
| 71 | acylglycerol homeostasis (GO:0055090) | 4.33029819 |
| 72 | triglyceride homeostasis (GO:0070328) | 4.33029819 |
| 73 | negative regulation of sterol transport (GO:0032372) | 4.31996010 |
| 74 | negative regulation of cholesterol transport (GO:0032375) | 4.31996010 |
| 75 | reverse cholesterol transport (GO:0043691) | 4.31978073 |
| 76 | regulation of cholesterol esterification (GO:0010872) | 4.29504473 |
| 77 | regulation of apoptotic cell clearance (GO:2000425) | 4.29100417 |
| 78 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27747876 |
| 79 | protein-lipid complex remodeling (GO:0034368) | 4.27747876 |
| 80 | macromolecular complex remodeling (GO:0034367) | 4.27747876 |
| 81 | intestinal absorption (GO:0050892) | 4.26303622 |
| 82 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.23719754 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.22692856 |
| 84 | protein-lipid complex subunit organization (GO:0071825) | 4.21204926 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 4.20138811 |
| 86 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.17445312 |
| 87 | cellular glucuronidation (GO:0052695) | 4.17445279 |
| 88 | bile acid and bile salt transport (GO:0015721) | 4.16770413 |
| 89 | flavonoid metabolic process (GO:0009812) | 4.15424846 |
| 90 | ethanol metabolic process (GO:0006067) | 4.11993786 |
| 91 | ethanol oxidation (GO:0006069) | 4.11633867 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.10711298 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 4.09668515 |
| 94 | * urate metabolic process (GO:0046415) | 4.09210490 |
| 95 | imidazole-containing compound metabolic process (GO:0052803) | 4.08783776 |
| 96 | aldehyde catabolic process (GO:0046185) | 4.06627254 |
| 97 | negative regulation of coagulation (GO:0050819) | 4.05793150 |
| 98 | hormone catabolic process (GO:0042447) | 4.05268447 |
| 99 | exogenous drug catabolic process (GO:0042738) | 4.05175035 |
| 100 | phospholipid efflux (GO:0033700) | 4.01019103 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 4.00258352 |
| 102 | negative regulation of wound healing (GO:0061045) | 3.98717185 |
| 103 | ketone body metabolic process (GO:1902224) | 3.97050728 |
| 104 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.95559157 |
| 105 | plasma lipoprotein particle clearance (GO:0034381) | 3.93661452 |
| 106 | aspartate family amino acid catabolic process (GO:0009068) | 3.93087664 |
| 107 | phenylpropanoid metabolic process (GO:0009698) | 3.92339574 |
| 108 | organic acid catabolic process (GO:0016054) | 3.91362215 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.91362215 |
| 110 | arginine metabolic process (GO:0006525) | 3.88515967 |
| 111 | lipoprotein metabolic process (GO:0042157) | 3.88094339 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.84818152 |
| 113 | cytolysis (GO:0019835) | 3.83758295 |
| 114 | alkaloid metabolic process (GO:0009820) | 3.81383983 |
| 115 | positive regulation of blood coagulation (GO:0030194) | 3.81178325 |
| 116 | positive regulation of hemostasis (GO:1900048) | 3.81178325 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.79142340 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.79142340 |
| 119 | 2-oxoglutarate metabolic process (GO:0006103) | 3.79097567 |
| 120 | proline metabolic process (GO:0006560) | 3.76806440 |
| 121 | drug transport (GO:0015893) | 3.75907394 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.74891266 |
| 123 | cholesterol efflux (GO:0033344) | 3.73630111 |
| 124 | regulation of cholesterol homeostasis (GO:2000188) | 3.72843377 |
| 125 | fibrinolysis (GO:0042730) | 3.71167249 |
| 126 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70455045 |
| 127 | negative regulation of complement activation (GO:0045916) | 3.64438401 |
| 128 | fatty acid beta-oxidation (GO:0006635) | 3.64316534 |
| 129 | fatty acid oxidation (GO:0019395) | 3.63934379 |
| 130 | cofactor catabolic process (GO:0051187) | 3.63430313 |
| 131 | monocarboxylic acid catabolic process (GO:0072329) | 3.62431534 |
| 132 | phospholipid homeostasis (GO:0055091) | 3.58987158 |
| 133 | low-density lipoprotein particle remodeling (GO:0034374) | 3.58753905 |
| 134 | lipid oxidation (GO:0034440) | 3.56942171 |
| 135 | carnitine metabolic process (GO:0009437) | 3.56941763 |
| 136 | plasma lipoprotein particle assembly (GO:0034377) | 3.56340962 |
| 137 | opsonization (GO:0008228) | 3.54015266 |
| 138 | * cholesterol homeostasis (GO:0042632) | 3.52506538 |
| 139 | drug metabolic process (GO:0017144) | 3.51916985 |
| 140 | response to mercury ion (GO:0046689) | 3.50896646 |
| 141 | positive regulation of coagulation (GO:0050820) | 3.50574704 |
| 142 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.50421713 |
| 143 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.50421713 |
| 144 | NAD biosynthetic process (GO:0009435) | 3.50288601 |
| 145 | * sterol homeostasis (GO:0055092) | 3.46526245 |
| 146 | angiotensin maturation (GO:0002003) | 3.44164403 |
| 147 | S-adenosylmethionine metabolic process (GO:0046500) | 3.41435341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34234091 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13726943 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.73018799 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44616861 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.17808163 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83366548 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.79262025 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99047100 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.85162950 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.14116774 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.13262681 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10441833 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6974643 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66422816 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.65267007 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62425851 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46866458 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37434711 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36085858 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31387541 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24684408 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17596334 |
| 23 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16822290 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14710749 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12854668 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06047826 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05570904 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05437201 |
| 29 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04986783 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04793627 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02369743 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02064714 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00839119 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97844248 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97672721 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89990575 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88511373 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88002806 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87055635 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86088436 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.85661492 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82728120 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81037584 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80724964 |
| 45 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80029114 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78196140 |
| 47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77364956 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74852722 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73947393 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73204209 |
| 51 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.72709257 |
| 52 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.72650134 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72522385 |
| 54 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71524998 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71491062 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70941536 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70268539 |
| 58 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.70260245 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69242752 |
| 60 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67863133 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67506819 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67506819 |
| 63 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.66724624 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.65903191 |
| 65 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65633487 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65344585 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65285865 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64883983 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.64480080 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64355653 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62977192 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62184620 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61377638 |
| 74 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.60959617 |
| 75 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.60325058 |
| 76 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.60162170 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59835938 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59737331 |
| 79 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.58737074 |
| 80 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.57042795 |
| 81 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.56745580 |
| 82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56591509 |
| 83 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.56507522 |
| 84 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.56401920 |
| 85 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55885954 |
| 86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.55790335 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.55695887 |
| 88 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55575654 |
| 89 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55370101 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55157683 |
| 91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.53902819 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53548319 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.53234152 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.53167575 |
| 95 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.52653514 |
| 96 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.52229366 |
| 97 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.52170024 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.52120531 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51382169 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.51205051 |
| 101 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50956859 |
| 102 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50344599 |
| 103 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49665207 |
| 104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.48705436 |
| 105 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47403675 |
| 106 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46920815 |
| 107 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46800073 |
| 108 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45382637 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45221324 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43485302 |
| 111 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43418757 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42353973 |
| 113 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42345714 |
| 114 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41812053 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41667258 |
| 116 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41484060 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.41452698 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.40349516 |
| 119 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40305447 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.40285766 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40007586 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39984296 |
| 123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.39957129 |
| 124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39946120 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39050278 |
| 126 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38537657 |
| 127 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37976985 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37718575 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37361155 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37271885 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.37187395 |
| 132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36687402 |
| 133 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.36637648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.16297988 |
| 2 | MP0005360_urolithiasis | 7.97861102 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.19709601 |
| 4 | MP0005365_abnormal_bile_salt | 5.91603453 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.99164495 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.02735507 |
| 7 | MP0003252_abnormal_bile_duct | 3.99646107 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.33849430 |
| 9 | MP0005332_abnormal_amino_acid | 3.23520381 |
| 10 | MP0003195_calcinosis | 3.21747376 |
| 11 | MP0009840_abnormal_foam_cell | 2.84393180 |
| 12 | MP0005083_abnormal_biliary_tract | 2.83647775 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.66894276 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.52370635 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.36500584 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.14196333 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.02572772 |
| 18 | * MP0002118_abnormal_lipid_homeostasis | 2.00661394 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.86259249 |
| 20 | MP0003868_abnormal_feces_composition | 1.75391690 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.68790485 |
| 22 | MP0001764_abnormal_homeostasis | 1.66902601 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65060068 |
| 24 | MP0005451_abnormal_body_composition | 1.52543619 |
| 25 | MP0003186_abnormal_redox_activity | 1.39119873 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.39109561 |
| 27 | MP0000566_synostosis | 1.38295533 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.30640539 |
| 29 | MP0009697_abnormal_copulation | 1.28102621 |
| 30 | MP0003011_delayed_dark_adaptation | 1.18045722 |
| 31 | MP0004043_abnormal_pH_regulation | 1.13541528 |
| 32 | * MP0000598_abnormal_liver_morphology | 1.11521700 |
| 33 | MP0003122_maternal_imprinting | 1.11519480 |
| 34 | MP0002132_abnormal_respiratory_system | 1.07570689 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.06342562 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.05920090 |
| 37 | MP0009764_decreased_sensitivity_to | 1.05614850 |
| 38 | MP0005647_abnormal_sex_gland | 1.04401841 |
| 39 | MP0001756_abnormal_urination | 1.01556905 |
| 40 | MP0003879_abnormal_hair_cell | 1.00555803 |
| 41 | MP0005670_abnormal_white_adipose | 0.96495800 |
| 42 | MP0000604_amyloidosis | 0.95590865 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 0.92682973 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.91816841 |
| 45 | MP0009763_increased_sensitivity_to | 0.91454821 |
| 46 | * MP0009642_abnormal_blood_homeostasis | 0.88507027 |
| 47 | MP0008469_abnormal_protein_level | 0.87813692 |
| 48 | MP0005409_darkened_coat_color | 0.87635600 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.86989548 |
| 50 | MP0002136_abnormal_kidney_physiology | 0.85118390 |
| 51 | MP0002254_reproductive_system_inflammat | 0.84721710 |
| 52 | MP0005408_hypopigmentation | 0.82355111 |
| 53 | MP0002089_abnormal_postnatal_growth/wei | 0.77860496 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.77396289 |
| 55 | MP0010368_abnormal_lymphatic_system | 0.76864129 |
| 56 | MP0005535_abnormal_body_temperature | 0.76719729 |
| 57 | MP0005376_homeostasis/metabolism_phenot | 0.75753696 |
| 58 | * MP0002078_abnormal_glucose_homeostasis | 0.74404450 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.73175804 |
| 60 | MP0001765_abnormal_ion_homeostasis | 0.72165146 |
| 61 | MP0001915_intracranial_hemorrhage | 0.71472916 |
| 62 | MP0001661_extended_life_span | 0.70781968 |
| 63 | MP0002971_abnormal_brown_adipose | 0.70559169 |
| 64 | MP0002928_abnormal_bile_duct | 0.64579376 |
| 65 | MP0005334_abnormal_fat_pad | 0.63785111 |
| 66 | MP0004130_abnormal_muscle_cell | 0.60773337 |
| 67 | MP0005266_abnormal_metabolism | 0.60407504 |
| 68 | MP0003329_amyloid_beta_deposits | 0.59701652 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.59642913 |
| 70 | MP0003690_abnormal_glial_cell | 0.57636250 |
| 71 | MP0009053_abnormal_anal_canal | 0.55855368 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.52768004 |
| 73 | MP0005395_other_phenotype | 0.52717531 |
| 74 | MP0010155_abnormal_intestine_physiology | 0.52673071 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.50144880 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.49057085 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.48982322 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.48595725 |
| 79 | MP0005448_abnormal_energy_balance | 0.46595305 |
| 80 | MP0002249_abnormal_larynx_morphology | 0.46477130 |
| 81 | MP0002168_other_aberrant_phenotype | 0.46421022 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.46360420 |
| 83 | MP0004147_increased_porphyrin_level | 0.45511905 |
| 84 | MP0002282_abnormal_trachea_morphology | 0.45269005 |
| 85 | MP0009785_altered_susceptibility_to | 0.44958596 |
| 86 | MP0003724_increased_susceptibility_to | 0.43720789 |
| 87 | MP0003953_abnormal_hormone_level | 0.43058556 |
| 88 | MP0008874_decreased_physiological_sensi | 0.42032099 |
| 89 | MP0000678_abnormal_parathyroid_gland | 0.40504433 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.40417452 |
| 91 | MP0008873_increased_physiological_sensi | 0.39840947 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.39794357 |
| 93 | MP0005166_decreased_susceptibility_to | 0.39178080 |
| 94 | MP0003075_altered_response_to | 0.38454268 |
| 95 | MP0002796_impaired_skin_barrier | 0.38368847 |
| 96 | MP0002822_catalepsy | 0.37298448 |
| 97 | MP0003718_maternal_effect | 0.37050083 |
| 98 | MP0009672_abnormal_birth_weight | 0.36617122 |
| 99 | MP0000538_abnormal_urinary_bladder | 0.36537081 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.35712704 |
| 101 | MP0008872_abnormal_physiological_respon | 0.35666463 |
| 102 | MP0002837_dystrophic_cardiac_calcinosis | 0.34850834 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.34595125 |
| 104 | MP0009780_abnormal_chondrocyte_physiolo | 0.33635646 |
| 105 | MP0004381_abnormal_hair_follicle | 0.33275757 |
| 106 | * MP0002135_abnormal_kidney_morphology | 0.33099777 |
| 107 | MP0004883_abnormal_blood_vessel | 0.33072796 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.32733293 |
| 109 | MP0003436_decreased_susceptibility_to | 0.31926024 |
| 110 | MP0009115_abnormal_fat_cell | 0.30371222 |
| 111 | MP0005164_abnormal_response_to | 0.30342462 |
| 112 | MP0004264_abnormal_extraembryonic_tissu | 0.29420159 |
| 113 | MP0006082_CNS_inflammation | 0.28868043 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.28025925 |
| 115 | MP0000579_abnormal_nail_morphology | 0.27886433 |
| 116 | MP0002970_abnormal_white_adipose | 0.27319564 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.27227807 |
| 118 | MP0005187_abnormal_penis_morphology | 0.27123345 |
| 119 | MP0005248_abnormal_Harderian_gland | 0.26448379 |
| 120 | MP0003959_abnormal_lean_body | 0.26097548 |
| 121 | MP0000249_abnormal_blood_vessel | 0.25084535 |
| 122 | MP0005377_hearing/vestibular/ear_phenot | 0.23330633 |
| 123 | MP0003878_abnormal_ear_physiology | 0.23330633 |
| 124 | MP0005551_abnormal_eye_electrophysiolog | 0.22640016 |
| 125 | MP0003866_abnormal_defecation | 0.21808362 |
| 126 | MP0005023_abnormal_wound_healing | 0.21220528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.17603483 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.96569321 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.65827061 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.34041356 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.80822396 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.75243996 |
| 7 | * Xanthomatosis (HP:0000991) | 5.60081291 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.96501336 |
| 9 | Complement deficiency (HP:0004431) | 4.93590196 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.82752515 |
| 11 | Hyperammonemia (HP:0001987) | 4.67809505 |
| 12 | Hyperglycinemia (HP:0002154) | 4.64246251 |
| 13 | Hyperglycinuria (HP:0003108) | 4.62724527 |
| 14 | Ketosis (HP:0001946) | 4.56323835 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.42059772 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.42059772 |
| 17 | Joint hemorrhage (HP:0005261) | 4.38321409 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.35976938 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31973108 |
| 20 | Hypolipoproteinemia (HP:0010981) | 4.27548178 |
| 21 | Epidermoid cyst (HP:0200040) | 4.18990813 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.99681174 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.96724984 |
| 24 | Fat malabsorption (HP:0002630) | 3.92155522 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.90238186 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.74679573 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.72975794 |
| 28 | Nephritis (HP:0000123) | 3.72700040 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69739478 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64962080 |
| 31 | Abnormality of complement system (HP:0005339) | 3.56077610 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.54333379 |
| 33 | Ketoacidosis (HP:0001993) | 3.51097743 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.35368871 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.34968708 |
| 36 | * Abnormality of nucleobase metabolism (HP:0010932) | 3.26170381 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.24876291 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.22130432 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.20378277 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.15692976 |
| 41 | * Abnormality of purine metabolism (HP:0004352) | 3.03348474 |
| 42 | Metabolic acidosis (HP:0001942) | 2.99393412 |
| 43 | Steatorrhea (HP:0002570) | 2.90766520 |
| 44 | Vascular calcification (HP:0004934) | 2.89536561 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80469635 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.80469635 |
| 47 | Alkalosis (HP:0001948) | 2.79670670 |
| 48 | Lethargy (HP:0001254) | 2.78401512 |
| 49 | Proximal tubulopathy (HP:0000114) | 2.75324540 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.75064306 |
| 51 | Myocardial infarction (HP:0001658) | 2.68418344 |
| 52 | Facial shape deformation (HP:0011334) | 2.67776321 |
| 53 | Potter facies (HP:0002009) | 2.67776321 |
| 54 | Spontaneous abortion (HP:0005268) | 2.61767968 |
| 55 | Purpura (HP:0000979) | 2.60121874 |
| 56 | Widely patent fontanelles and sutures (HP:0004492) | 2.60093405 |
| 57 | Malnutrition (HP:0004395) | 2.59729616 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.58876818 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.56814288 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.56638261 |
| 61 | Skin nodule (HP:0200036) | 2.56407614 |
| 62 | Osteomalacia (HP:0002749) | 2.54725812 |
| 63 | Spastic diplegia (HP:0001264) | 2.53487462 |
| 64 | * Gout (HP:0001997) | 2.53028162 |
| 65 | Irritability (HP:0000737) | 2.52164872 |
| 66 | Neonatal onset (HP:0003623) | 2.50937821 |
| 67 | * Hepatocellular carcinoma (HP:0001402) | 2.49755240 |
| 68 | Abnormality of vitamin metabolism (HP:0100508) | 2.47295926 |
| 69 | Cerebral edema (HP:0002181) | 2.44495114 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 2.38350632 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.38350632 |
| 72 | Vomiting (HP:0002013) | 2.36668439 |
| 73 | Rickets (HP:0002748) | 2.33432846 |
| 74 | Mitral stenosis (HP:0001718) | 2.31556539 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.31171790 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.30961303 |
| 77 | Hyperphosphaturia (HP:0003109) | 2.30412606 |
| 78 | Abnormality of urine glucose concentration (HP:0011016) | 2.28197651 |
| 79 | Glycosuria (HP:0003076) | 2.28197651 |
| 80 | Acanthocytosis (HP:0001927) | 2.27588749 |
| 81 | Poikilocytosis (HP:0004447) | 2.25039109 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.23422794 |
| 83 | Glomerulonephritis (HP:0000099) | 2.20659099 |
| 84 | Cholelithiasis (HP:0001081) | 2.18702753 |
| 85 | Late onset (HP:0003584) | 2.18465300 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.17035975 |
| 87 | Cholecystitis (HP:0001082) | 2.17035975 |
| 88 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.14723339 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11791649 |
| 90 | Pulmonary embolism (HP:0002204) | 2.09886508 |
| 91 | Esophageal varix (HP:0002040) | 2.08830963 |
| 92 | Abnormal urine phosphate concentration (HP:0012599) | 2.08052672 |
| 93 | Pigmentary retinal degeneration (HP:0001146) | 2.07614378 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 2.01317852 |
| 95 | Brushfield spots (HP:0001088) | 1.99908810 |
| 96 | Opisthotonus (HP:0002179) | 1.99362246 |
| 97 | * Hyperuricemia (HP:0002149) | 1.98139960 |
| 98 | * Increased purine levels (HP:0004368) | 1.98139960 |
| 99 | Hypophosphatemia (HP:0002148) | 1.97541579 |
| 100 | * Pancreatitis (HP:0001733) | 1.96421182 |
| 101 | Amyloidosis (HP:0011034) | 1.96367096 |
| 102 | Thrombophlebitis (HP:0004418) | 1.95423549 |
| 103 | Menorrhagia (HP:0000132) | 1.92883428 |
| 104 | Arthropathy (HP:0003040) | 1.92468964 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.91586822 |
| 106 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90963578 |
| 107 | Megaloblastic anemia (HP:0001889) | 1.90842481 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 1.87834027 |
| 109 | Elevated alkaline phosphatase (HP:0003155) | 1.87807965 |
| 110 | Confusion (HP:0001289) | 1.86513259 |
| 111 | Fair hair (HP:0002286) | 1.86224466 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85566794 |
| 113 | Hemorrhage of the eye (HP:0011885) | 1.84607110 |
| 114 | Joint swelling (HP:0001386) | 1.83618311 |
| 115 | Gingival bleeding (HP:0000225) | 1.83393953 |
| 116 | Renal cortical cysts (HP:0000803) | 1.81984026 |
| 117 | Hypokalemic alkalosis (HP:0001949) | 1.81037936 |
| 118 | Ileus (HP:0002595) | 1.70192804 |
| 119 | Epistaxis (HP:0000421) | 1.66230312 |
| 120 | Gangrene (HP:0100758) | 1.64948946 |
| 121 | Bifid scrotum (HP:0000048) | 1.64021167 |
| 122 | Increased serum ferritin (HP:0003281) | 1.63163432 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.62936966 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60728255 |
| 125 | Wide cranial sutures (HP:0010537) | 1.60642599 |
| 126 | Abnormal tarsal ossification (HP:0008369) | 1.59890111 |
| 127 | * Nephrolithiasis (HP:0000787) | 1.59748498 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.59018420 |
| 129 | Cerebral palsy (HP:0100021) | 1.58355176 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.56686735 |
| 131 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.55314794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.10315719 |
| 2 | FGFR4 | 4.28922227 |
| 3 | ERN1 | 3.93356159 |
| 4 | SIK1 | 3.88949295 |
| 5 | ACVR1B | 3.76016061 |
| 6 | WNK4 | 2.83042606 |
| 7 | WNK3 | 2.79129864 |
| 8 | INSRR | 2.77722699 |
| 9 | ERBB4 | 2.77202992 |
| 10 | TAOK3 | 2.64278818 |
| 11 | PIK3CA | 2.51295176 |
| 12 | OXSR1 | 2.36626909 |
| 13 | MST1R | 2.20118018 |
| 14 | MAP2K4 | 2.03488823 |
| 15 | AKT3 | 1.95830499 |
| 16 | MAPK11 | 1.86657067 |
| 17 | PKN2 | 1.84742598 |
| 18 | NTRK3 | 1.76516050 |
| 19 | PRKG2 | 1.61577271 |
| 20 | STK38L | 1.57324207 |
| 21 | PIK3CG | 1.53636000 |
| 22 | FLT3 | 1.52911945 |
| 23 | LATS1 | 1.52855671 |
| 24 | TRIB3 | 1.51840111 |
| 25 | MAP3K2 | 1.48594794 |
| 26 | ABL2 | 1.43956801 |
| 27 | TYK2 | 1.42327182 |
| 28 | PTK6 | 1.38939821 |
| 29 | FRK | 1.38644028 |
| 30 | EPHA2 | 1.35425929 |
| 31 | DAPK2 | 1.33985146 |
| 32 | PINK1 | 1.32643388 |
| 33 | MAP3K7 | 1.26990497 |
| 34 | FGFR1 | 1.21684636 |
| 35 | NEK9 | 1.20561697 |
| 36 | FGFR2 | 1.17170986 |
| 37 | PRKAA2 | 1.13386284 |
| 38 | GRK6 | 1.12821243 |
| 39 | JAK2 | 1.11349605 |
| 40 | KDR | 1.08191353 |
| 41 | TYRO3 | 1.05801746 |
| 42 | PDGFRA | 1.03387769 |
| 43 | SGK494 | 0.99377083 |
| 44 | SGK223 | 0.99377083 |
| 45 | DDR2 | 0.96341414 |
| 46 | STK39 | 0.95901281 |
| 47 | MAPK15 | 0.94945141 |
| 48 | ERBB2 | 0.94594386 |
| 49 | NLK | 0.94435799 |
| 50 | SGK3 | 0.93724928 |
| 51 | EPHB1 | 0.92634442 |
| 52 | MAP3K14 | 0.91491186 |
| 53 | MAP2K3 | 0.90335396 |
| 54 | PRKCZ | 0.88465337 |
| 55 | TIE1 | 0.87673190 |
| 56 | MAP3K3 | 0.87062227 |
| 57 | WNK1 | 0.86440959 |
| 58 | GSK3A | 0.85908050 |
| 59 | MAPK4 | 0.85645651 |
| 60 | TBK1 | 0.83431475 |
| 61 | PDK4 | 0.83122162 |
| 62 | PDK3 | 0.83122162 |
| 63 | MAP3K10 | 0.82664032 |
| 64 | JAK1 | 0.82488077 |
| 65 | SGK2 | 0.82155263 |
| 66 | MET | 0.81671688 |
| 67 | DYRK1B | 0.79308691 |
| 68 | PRKAA1 | 0.77591044 |
| 69 | BCR | 0.74624759 |
| 70 | MAPK12 | 0.73033584 |
| 71 | PRKACG | 0.71907533 |
| 72 | MATK | 0.69453829 |
| 73 | PRKG1 | 0.67152921 |
| 74 | IRAK3 | 0.64985366 |
| 75 | TGFBR2 | 0.64007559 |
| 76 | PRKACA | 0.63473562 |
| 77 | PTK2 | 0.63436725 |
| 78 | SGK1 | 0.62873595 |
| 79 | CAMK2G | 0.61235148 |
| 80 | MAPKAPK3 | 0.61223082 |
| 81 | MAP3K11 | 0.61119095 |
| 82 | CDK6 | 0.60030356 |
| 83 | CSK | 0.59763847 |
| 84 | RIPK1 | 0.59113921 |
| 85 | FER | 0.58777669 |
| 86 | PDPK1 | 0.57454230 |
| 87 | BRSK2 | 0.56621388 |
| 88 | SIK2 | 0.55839456 |
| 89 | MAP2K6 | 0.53373875 |
| 90 | CAMK1D | 0.52908964 |
| 91 | NEK1 | 0.52851405 |
| 92 | SRC | 0.51506708 |
| 93 | CDC42BPA | 0.49626495 |
| 94 | CAMKK2 | 0.49097419 |
| 95 | CSNK1E | 0.48707145 |
| 96 | EPHA3 | 0.48370447 |
| 97 | PDK2 | 0.45280351 |
| 98 | MAPK7 | 0.45065386 |
| 99 | CSNK1G1 | 0.44654367 |
| 100 | PRKCQ | 0.44554775 |
| 101 | CDK12 | 0.42883718 |
| 102 | STK38 | 0.42134265 |
| 103 | FGFR3 | 0.41484064 |
| 104 | RPS6KB1 | 0.39950986 |
| 105 | CSF1R | 0.39697184 |
| 106 | CASK | 0.38224790 |
| 107 | IGF1R | 0.37341795 |
| 108 | IKBKE | 0.36781748 |
| 109 | TNIK | 0.36150973 |
| 110 | ITK | 0.35571248 |
| 111 | PDK1 | 0.35436437 |
| 112 | EPHA4 | 0.35393644 |
| 113 | GRK1 | 0.35070997 |
| 114 | PRKCB | 0.34815650 |
| 115 | PKN1 | 0.34660983 |
| 116 | MAP4K2 | 0.34536930 |
| 117 | PRKCG | 0.34457806 |
| 118 | LMTK2 | 0.33852543 |
| 119 | RPS6KA3 | 0.33480231 |
| 120 | ADRBK2 | 0.33227055 |
| 121 | MTOR | 0.32406398 |
| 122 | CSNK1D | 0.32262495 |
| 123 | FGR | 0.31818800 |
| 124 | MAP2K1 | 0.30676093 |
| 125 | MAPK3 | 0.29734065 |
| 126 | MAP3K5 | 0.29426072 |
| 127 | IRAK2 | 0.29151359 |
| 128 | ICK | 0.28760937 |
| 129 | MAP3K13 | 0.28675614 |
| 130 | RET | 0.27503934 |
| 131 | PAK3 | 0.27220389 |
| 132 | CAMK4 | 0.27013698 |
| 133 | EGFR | 0.26852668 |
| 134 | MAP3K6 | 0.26288366 |
| 135 | PRKCA | 0.26070075 |
| 136 | CSNK1A1 | 0.26043844 |
| 137 | PRKACB | 0.25439488 |
| 138 | CDK4 | 0.23570145 |
| 139 | IRAK1 | 0.23350914 |
| 140 | BMX | 0.23062364 |
| 141 | MAP3K1 | 0.21929784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30017569 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43159008 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41751072 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40925441 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91628483 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.79406465 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72601698 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62884599 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57600479 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55028125 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54163209 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48873681 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40311570 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37147353 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.21270228 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13952494 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01672481 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88588665 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85640096 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84863373 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84377044 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80644444 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80136683 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77824256 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77361534 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71693373 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70588810 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65511437 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65217058 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58183926 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58005649 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.57369965 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56503324 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53884225 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52629050 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51733735 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42924398 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35934855 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34604814 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34203338 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31764529 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29954541 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24535348 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23496051 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23385780 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21711771 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19139648 |
| 48 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14913164 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.13489464 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12448144 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05793847 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03753934 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02583048 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00153523 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.90644303 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87707048 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87674989 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83765778 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81860631 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78126322 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76584564 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72596857 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69453495 |
| 64 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68766158 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59373301 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48102709 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43620027 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.36275299 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33316630 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.27812526 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26643907 |
| 72 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23455708 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21996347 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21016943 |
| 75 | * Insulin resistance_Homo sapiens_hsa04931 | 0.16855064 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14224679 |
| 77 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12607939 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11830635 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10983142 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09737755 |
| 81 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03121013 |
| 82 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.01242021 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.01068474 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.2217049 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2213062 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2109525 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | -0.2051468 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1962736 |
| 89 | Lysosome_Homo sapiens_hsa04142 | -0.1938337 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1834254 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1746317 |
| 92 | * Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1641990 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1630578 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1308987 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1271535 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1266318 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1209717 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | -0.1131556 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1086427 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.1028463 |
| 101 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1007779 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1005913 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0959309 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0709195 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0525318 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0475935 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0329030 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0294623 |
| 109 | * AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0290466 |

